1-bromo-(S)-3-<(tert-butoxycarbonyl)amino>-4-<4'-<(3'-carbethoxypropyl)oxy>phenyl>-2-butanone | 171858-34-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-bromo-(S)-3-<(tert-butoxycarbonyl)amino>-4-<4'-<(3'-carbethoxypropyl)oxy>phenyl>-2-butanone
• 英文别名: 1-Bromo-(S)-3-(t-butoxycarbonylamino)-4-(4'-[3'-carboethoxy]propyloxy)phenyl-2-butanone；ethyl 4-[4-[(2S)-4-bromo-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-oxobutyl]phenoxy]butanoate
• CAS: 171858-34-7
• 化学式: C₂₁H₃₀BrNO₆
• 分子量: 472.376
• InChiKey: QALFKJFCCZSDSI-KRWDZBQOSA-N

物化性质

• 沸点：
  578.5±50.0 °C(Predicted)
• 密度：
  1.273±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  29
• 可旋转键数：
  14
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  90.9
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  1-bromo-(S)-3-<(tert-butoxycarbonyl)amino>-4-<4'-<(3'-carbethoxypropyl)oxy>phenyl>-2-butanone 在 盐酸 、 sodium hydroxide 、 sodium tetrahydroborate 、 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 、 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下， 生成
  参考文献：
  名称：

  Structure-activity relationships for macrocyclic peptidomimetic inhibitors of HIV-1 protease

  摘要：

  A rational approach to developing inhibitors of proteolytic enzymes is the systematic modification of their peptide substrates to proteolytically stable, low molecular weight, nonpeptidic inhibitors. Replacing the scissile amide bond with a noncleavable transition state isostere usually gives potent protease inhibitors, but the remaining hydrolysable amide bonds render the inhibitors unstable to peptidases generally. Attempts to replace them with retention of inhibitor potency has proved difficult(1,2) due to the unpredictable cooperative influences of such variations on the conformations of both neighbouring inhibitor groups and enzyme residues. We recently described a method(3) for regioselectively fixing the conformation of inhibitor components and now show effects on activity of varying both the 'free' and 'fixed' components.

  DOI：

  10.1016/0960-894x(96)00468-4
• 作为产物：
  描述：

  ethyl 4-<4'-<<2-<(tert-butoxycarbonyl)amino>-2-carboxy>ethyl>phenoxy>butanoate 在 N-甲基哌啶 、 氢溴酸 作用下， 以 四氢呋喃 、 乙酸乙酯 为溶剂， 反应 1.17h， 生成 1-bromo-(S)-3-<(tert-butoxycarbonyl)amino>-4-<4'-<(3'-carbethoxypropyl)oxy>phenyl>-2-butanone
  参考文献：
  名称：

  Regioselective structural and functional mimicry of peptides. Design of hydrolytically-stable cyclic peptidomimetic inhibitors of HIV-1 protease.

  摘要：

  Hydrolytically-stable cyclic mimetics of the tripeptides Leu-Asn-Phe and Phe-Ile-Val were designed and incorporated into peptidic inhibitors, Ac-{Leu-Asn-Phe}-CHOHCH2-Pro-Ile-Val-NH2 and Ac-Leu-Val-Phe-CHOHCH2-{Phe-Ile-Val}-NH2, of HIV-1 protease. Structural mimicry has been established through molecular modeling and X-ray crystallographic studies of inhibitors bound to HIV-1 protease. Cyclic and acyclic inhibitors had similar conformations that were superimposable and formed similar interactions with the enzyme. Functional mimicry was demonstrated by comparable inhibition of the protease by acyclic and cyclic molecules. Further substitution of the residual acyclic Pro-Ile-Val or Leu-Val-Phe inhibitor components, with Pip-NHtBu or Boc-Phe, respectively, gave hydrolytically stable, water-soluble, lipophilic inhibitors of similar potency. The use of cycles to fix the conformations of amino acid sequences in peptides allows regioselective structural mimicry leading to functional mimicry and also permits localized structure-activity optimization in inhibitors of HIV-1 protease. This approach might be usefully applied to inhibitors of other proteins.

  DOI：

  10.1021/ja00146a007

文献信息

• HIV protease inhibitors
  申请人：The University of Queensland

  公开号：US06043357A1

  公开（公告）日：2000-03-28

  A HIV-1 protease inhibitor which includes a n-terminal cycle (A) or a C-terminal cycle (B) or both cycles (A) and (B) wherein Y is selected from side chains of Asn or Ilc or Val or Glu and alkyl of 1-6 carbon atoms inclusive of linear branched chains as well as cycloalkyl; and X is selected from (CH2)n where n=3-6, --CH(OH)--CH(OH)--CH2; CH(CO2H)--CH2--CH2; CH2CONHCHR where R=D or L amino acids and alkyl of 1-6 carbon atoms inclusive of linear or branched chains.

  一种HIV-1蛋白酶抑制剂，包括N-末端环(A)或C-末端环(B)或两个环(A)和(B)，其中Y选自Asn或Ilc或Val或Glu的侧链和1-6个碳原子的直链或支链烷基以及环烷基; X选自(CH2)n，其中n = 3-6，--CH(OH)--CH(OH)-- ; CH(CO2H)-- -- ; CONHCHR，其中R = D或L氨基酸和1-6个碳原子的直链或支链烷基。